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Embryonic hematopoietic development in the 
mouse proceeds through defined stages. The 
first hematopoietic cells of the erythroid lin-
eage develop in the extraembryonic yolk sac at 
embryonic day 7.5 (E7.5; Moore and Metcalf, 
1970). At E9, hematopoietic stem cell (HSC) 
activity from the yolk sac and paraaortic splanch-
nopleura (PSp) can be detected when trans-
planted into neonatal mice (Yoder et al., 1997; 
Arora et al., 2014). HSCs that engraft lethally 
irradiated adult recipients emerge in the aorta–
gonad–mesonephros (AGM) region at E10-11 
(Medvinsky and Dzierzak, 1996; North et al., 
2002). These HSCs later colonize additional 
organs required for adult hematopoiesis and 
possess the ability to reconstitute multiple he-
matopoietic lineages.
The development of the murine circulatory 
system at E8.5 coincides with the development 
of more definitive hematopoietic compartments, 
including HSCs and the lymphoid lineage. Ac-
cordingly, recent studies have linked biome-
chanical forces, such as blood flow–induced shear 
stress, to hematopoietic development (Adamo 
et al., 2009; North et al., 2009). In these stud-
ies, genetic mutants lacking intravascular circu-
lation were used to demonstrate the reduction 
in hematopoietic emergence in the AGM and 
nitric oxide signaling was implicated in blood 
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Fluid shear stress promotes the emergence of hematopoietic stem cells (HSCs) in the aorta–
gonad–mesonephros (AGM) of the developing mouse embryo. We determined that the AGM 
is enriched for expression of targets of protein kinase A (PKA)–cAMP response element-
binding protein (CREB), a pathway activated by fluid shear stress. By analyzing CREB ge-
nomic occupancy from chromatin-immunoprecipitation sequencing (ChIP-seq) data, we 
identified the bone morphogenetic protein (BMP) pathway as a potential regulator of CREB. 
By chemical modulation of the PKA–CREB and BMP pathways in isolated AGM VE-
cadherin+ cells from mid-gestation embryos, we demonstrate that PKA–CREB regulates 
hematopoietic engraftment and clonogenicity of hematopoietic progenitors, and is depen-
dent on secreted BMP ligands through the type I BMP receptor. Finally, we observed blunt-
ing of this signaling axis using Ncx1-null embryos, which lack a heartbeat and intravascular 
flow. Collectively, we have identified a novel PKA–CREB–BMP signaling pathway down-
stream of shear stress that regulates HSC emergence in the AGM via the endothelial-to-
hematopoietic transition.
© 2015 Kim et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Ncx1-null embryos, which lack a heartbeat and intravascular 
flow. Our data thus document a blood-flow dependent path-
way regulating hematopoietic development.
RESULTS
CREB activation in the AGM
To assess the role of the CREB pathway in hematopoie-
sis, we examined CREB-mediated gene expression programs 
across various embryonic and adult hematopoietic tissues and 
found marked enrichment of CREB target genes in the 
aorta-gonad-mesonephros (AGM) relative to other tissues 
(Fig. 1 A; McKinney-Freeman et al., 2012). CREB mRNA 
expression was similar among hematopoietic tissues, suggest-
ing a posttranscriptional mechanism of target gene activation 
(Fig. 1 B). Because phospho-CREB at S133 is required for its 
transcriptional activity (Gonzalez and Montminy, 1989), we 
examined the distribution of S133-phosphorylated CREB in 
the E11.5 AGM, a time point coinciding with HSC emer-
gence from the endothelium (North et al., 2002; Chen et al., 
2009; Bertrand et al., 2010; Boisset et al., 2010). Some cells 
lining the aortic endothelium were S133 phosphorylated 
(Fig. 1 C), which raises the possibility of a shear stress–mediated 
effect. We also examined phospho-CREB in E10.5 em-
bryos and obtained similar results (Fig. 1 D). Interestingly, 
most cells that were positive for Sca1-GFP, which marks the 
emerging HSCs in the endothelium (de Bruijn et al., 2002; 
Chen et al., 2011), also coexpressed phospho-CREB (Fig. 1 E). 
Because other S133-phosphorylated regions also included the 
ventral mesenchyme, notochord and the neural tube (Fig. 1, 
C and D), we examined the relationship between phospho-
CREB and shear stress more closely in isolated VE-cadherin+ 
cells from differentiated mESCs, which is a more accessible 
endothelial cell type. Shear stress increased S133 phosphory-
lation of CREB in a time-dependent manner (Fig. 1 F). The 
concomitant phosphorylation of -catenin at S675, a unique 
site for protein kinase A (PKA) phosphorylation (Hino et al., 
2005), indicated shear-induced PKA activity (Fig. 1 F). There-
fore, PKA phosphorylation of CREB in the AGM is likely 
dependent on blood flow.
Genomic binding and interaction of CREB in K562 cells
We next took advantage of published microarray data on 
CREB overexpression in human leukemic K562 cells as a 
model of hematopoietic stem/progenitor cells to gain insight 
into the role of the PKA–CREB pathway (Esparza et al., 
2008). To correlate gene transcription with transcription factor 
binding to the genome, we examined the active promoters of 
447 genes that were up-regulated by CREB overexpression 
(p-value cut-off, 0.05) for CREB genomic occupancy by an-
alyzing the K562 chromatin immunoprecipitation-sequencing 
(ChIP-seq) data (Fig. 2 A; Raney et al., 2011). We defined 
active promoters as having histone H3K4 trimethylation 
(H3K4me3) and H3K27 acetylation (H3K27ac) but lacking 
H3K27 trimethylation (H3K27me3; Barski et al., 2007; Koch 
et al., 2007). We screened for regulators of the CREB path-
way by examining transcription factor co-occupancy (Fig. 2 B). 
flow–dependent AGM hematopoiesis (Adamo et al., 2009; 
North et al., 2009; Wang et al., 2011). Although chimeric 
analysis demonstrated a cell autonomous requirement for ni-
tric oxide signaling in zebrafish (North et al., 2009), whether 
this pathway directly promotes hematopoiesis remains an open 
question due to the vasodilatory effect of nitric oxide donors 
and their effects on smooth muscle. Apart from these obser-
vations, signaling pathways responsible for flow-dependent 
hematopoietic induction have not been characterized.
Activation of protein kinase A (PKA) and its downstream 
target cAMP response element-binding protein (CREB) by 
exogenous shear stress has been observed in diverse cell 
types, including chondrocytes and osteocytes (Cherian et al., 
2003; Ogawa et al., 2014). The classic mechanism of PKA 
activation involves the binding of a ligand to a G protein–
coupled receptor and activation of adenylyl cyclase, which 
converts ATP into the second messenger cyclic AMP (cAMP). 
The binding of cAMP to PKA releases catalytic subunits 
that phosphorylate CREB in the nucleus. In differentiat-
ing mouse embryonic stem cells (mESCs), PKA–CREB has 
been linked to endothelial and hematopoietic differentiation 
via binding of CREB to the Etv2 promoter, which up-regulates 
pro-hematopoietic factors such as Gata2 and Scl/Tal1 (Yamamizu 
et al., 2012). Moreover, the PKA–CREB signaling pathway 
has been explored in the context of the prostaglandin E2 
signaling pathway in zebrafish, where it promotes AGM 
hematopoiesis via activation of the Wnt pathway (Goessling 
et al., 2009). However, whether this pathway is conserved 
in the mouse is unclear, especially given conflicting reports 
on Wnt signaling in AGM hematopoiesis (Ruiz-Herguido 
et al., 2012; Chanda et al., 2013). Prostaglandin E2 also di-
rectly activates several pathways including PI3K–AKT and 
ERK–MAPK, which makes it difficult to conclude that 
PKA–CREB is the sole mediator of the pro-hematopoietic 
effects of this molecule (Alfranca et al., 2006). Given the 
shear-responsiveness of the PKA–CREB pathway and its 
implication in early embryonic hematopoiesis in other spe-
cies, we investigated the possible role of shear stress–acti-
vated PKA–CREB signaling during AGM hematopoiesis in 
the mouse.
We first verified that this pathway is activated by shear 
stress in VE-cadherin+ endothelial cells and present in the 
murine AGM, specifically in the cells lining the dorsal aorta. 
We then conducted a bioinformatics-based screen using mi-
croarray data on CREB overexpression and CREB chroma-
tin immunoprecipitation-sequencing (ChIP-Seq) data using 
data available at Encyclopedia of DNA Elements (ENCODE) 
and elsewhere to identify regulators of CREB function in 
hematopoietic cells (Esparza et al., 2008; Jolma et al., 2010; 
Pencovich et al., 2011; Raney et al., 2011; Trompouki et al., 
2011; Martens et al., 2012). Using insight gained from bioin-
formatics, we discover that the bone morphogenetic protein 
(BMP) signaling pathway acts downstream of PKA–CREB 
signaling in regulating AGM hematopoiesis. Finally, we show 
that this is a blood flow–dependent pathway by demonstrat-
ing the abrogation of PKA–CREB–BMP signaling axis in 
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monomethylation (H3K4me1) and H3K27ac marks in the 
absence of H3K4me3 (Creyghton et al., 2010). CREB bound 
active enhancers less than promoters, which is in agreement 
with the preferential promoter distribution of CREB in other 
cell types (Fig. 2 D; Zhang et al., 2005). However, SMAD1 
still overlapped these CREB enhancer peaks (Fig. 2 D). To 
investigate the biological function of the genes co-bound by 
both CREB and SMAD1, we analyzed the top 3,000 genes 
with the strongest enrichment for CREB and SMAD1 peaks 
for PANTHER pathway annotation (Mi et al., 2007). Genes 
of co-bound peaks were annotated for hematopoietic cell ac-
tivation, angiogenesis, and VEGF signaling pathway (Fig. 2 E). 
To strengthen our claim regarding CREB and SMAD1 ge-
nomic co-occupancy, we treated K562 cells with forskolin 
The top CREB co-occupants within promoters of genes up-
regulated by CREB overexpression included PLU.1, THAP1, 
MYC, CEBPD, E2F4, and SMAD1 (Fig. 2 B). Among these 
top hits were two direct effectors of BMP signaling. SMAD1 
is a direct target of BMP receptors and is responsible for their 
downstream transcriptional activity (Kretzschmar et al., 1997), 
and E2F4 is known to be a SMAD cofactor (Chen et al., 
2002). Therefore, we investigated the interaction between 
CREB and the BMP pathway target SMAD1.
As this analysis was restricted to genes responding to 
CREB overexpression, we also analyzed global genomic 
occupancy in active promoters and enhancers. SMAD1 and 
CREB peaks were enriched near active promoters (Fig. 2 C). 
Active enhancers are defined by the presence of H3K4 
Figure 1. Phosphorylated CREB is pres-
ent in the AGM and increased by shear 
stress. (A) Gene set enrichment analysis for 
CREB target genes using the two-sample 
Kolmogorov–Smirnov test comparing each 
hematopoietic tissue against an ESC–derived 
embryoid body (EB). FL, fetal liver; YS, yolk 
sac; EPOCH, HoxB4 induced. Data are from 
McKinney-Freeman et al. (2012; GSE37000). 
(B) Expression of CREB across various hema-
topoietic tissues. (C) Immunofluorescence 
section of E11.5 AGM showing the localiza-
tion of phospho-CREB (pCREB) in the cells 
lining the endothelium and ventral mesen-
chyme. ao, dorsal aorta; nc, notochord; nt, 
neural tube, vm, ventral mesenchyme. Bar, 
100 µm. (D) Immunofluorescence section of 
E10.5 AGM showing the localization of 
pCREB and Sca1-GFP. ao, dorsal aorta; nc, 
notochord; nt, neural tube, vm, ventral mes-
enchyme. Arrows indicate double positive 
cells. Bars, 100 µm. (E) Quantification of 
pCREB+ in Sca1+ population and Sca1+ in 
pCREB+ population in cells lining the dorsal 
aorta. n = 5. (F) Immunoblot of VE-cadherin+ 
cells from differentiated mESCs that were 
exposed to shear stress for 6 h.
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Figure 2. Genomic interaction of CREB and SMAD1 in K562 cells. (A) Experimental schema showing the strategy for analysis of CREB-overexpression 
and genomic occupancy. (B) Top two quartiles of top CREB co-occupants in promoters of genes responding to CREB overexpression. Rows indicate genes 
up-regulated by CREB-overexpression and columns indicate binding of TFs. (C) Global CREB and SMAD1 promoter co-occupancy at active promoters.  
(D) SMAD1 co-occupancy at CREB-bound enhancers. (E) Annotation of top 3,000 scoring CREB and SMAD1 co-bound genes using PANTHER PATHWAY 
annotation. (F) Validation of CREB and SMAD1 genomic occupancy with phospho-CREB and phospho-Smad1/5/8 ChIP-seq. Genomic view of CREB  
and SMAD1 binding in the (G) ID1, (H) ID2, (I) ID3, (J) GATA2, (K) ETV5, and (L) FOS gene region. Phastcons track shows species conservation between  
46 species.
JEM Vol. 212, No. 5
Article
637
AGM (Fig. 3 G). In support of a PKA–CREB–BMP signaling 
interaction, BMP4 treatment of 4 ng/ml rescued hematopoi-
etic CFUs when PKA–CREB was inhibited (Fig. 3 G). We 
obtained similar results when we repeated the experiment 
with E10.5 AGM (Fig. 3 H). However, when we treated VE-
cadherin cells, which includes CD41+/CD45+ hematopoi-
etic precursors (North et al., 2002; Kim et al., 2013), the 
treatment had no effect, suggesting that the effect is specific 
to VE-cadherin+ cells (Fig. 3 I). Because KT5720 has non-
specific targets in addition to its effect on PKA, we used an-
other PKA inhibitor, H89, which has no other overlapping 
nonspecific targets, and found similar effects (0.5–2 µM; un-
published data; Davies et al., 2000). Rescue of hematopoietic 
CFUs suggests that BMP4 acts downstream of PKA–CREB 
signaling in ex vivo culture.
To assess the hematopoietic function of PKA–CREB 
in vivo, we transplanted isolated E11.5 VE-cadherin+ cells that 
were exposed to chemical compounds or ligands into lethally 
irradiated adult recipients. We monitored donor chimerism 
based on the percentage of CD45.2+ donor cells and assessed 
lineage contribution based on Gr+/Mac1+ myeloid cells, 
CD3+ T cells, and B220+ B cells (Fig. 3 J). Exposure to 5 µM 
of KT5720 reduced the percentage of donor chimerism as 
compared with the DMSO-treated controls (Fig. 3 K). Alter-
natively, BMP4 treatment rescued the percentage of donor 
chimerism from PKA–CREB inhibition (Fig. 3 K). These re-
sults suggest that PKA–CREB is required for in vivo hema-
topoietic activity and that BMP4 can compensate for the 
inhibition of PKA–CREB.
Smad signaling is correlated with PKA–CREB activation
We explored the temporal dynamics of PKA–CREB and 
BMP signaling activation to investigate a link between these 
pathways. We used high-content immunofluorescence to quan-
tify the levels of phospho-CREB and phospho-Smad1/5/8 
on a single-cell level over time using VE-cadherin+ cells from 
differentiating mESCs. Activation of the PKA–CREB path-
way using forskolin, an adenylyl cyclase activator, increased 
phospho-CREB in a dose-dependent manner (Fig. 4 A). 
When we quantified phospho-Smad1/5/8 over time in for-
skolin-treated cells, we saw an increase concomitant with an 
increase in phospho-CREB (Fig. 4 B). Both doses of for-
skolin increased phospho-Smad1/5/8 at 2 h after treatment, 
with the higher dose downtrending toward 8 h and the lower 
dose uptrending. When compared with BMP4-treated cells, 
phospho-Smad1/5/8 in forskolin-treated cells displayed dis-
tinct temporal dynamics. Collectively, phospho-Smad1/5/8 
dynamics correlate with that of phospho-CREB.
Forskolin treatment promotes AGM hematopoiesis
In the absence of exogenous BMP ligands in culture, the 
presence of phospho-Smad1/5/8 in forskolin-treated cells 
suggests that PKA–CREB activates the BMP pathway to 
promote AGM hematopoiesis. We treated VE-cadherin+ 
cells from the E11.5 AGM with forskolin and observed a 
significant increase in the number and size of multipotent 
or BMP and performed ChIP-sequencing using phospho-
CREB or phospho-Smad1/5/8 antibodies and obtained 
similar results (Fig. 2 F). Although K562 is a committed he-
matopoietic cell, the co-bound regions raise the hypothesis 
that these pathways regulate both hematopoietic and endo-
thelial genes.
We explored this hypothesis further in the context of spe-
cific genes. First, we examined CREB and SMAD1 occu-
pancy of early BMP response genes of the pathway ID1-3, 
some of which have known roles in vasculogenesis (Lyden 
et al., 1999). In the genomic region containing these genes, we 
found binding of both CREB and SMAD1 in the promoters 
(marked by H3K4me3) and enhancers (marked by H3K4me1) 
in highly conserved regions (Fig. 2, G–I). In addition to the 
early response genes, we also a observed similar co-occupancy 
within the GATA2 promoter (Fig. 2 J), a known regulator of 
AGM hematopoiesis (Ling et al., 2004); ETV5 (Fig. 2 K), 
which is expressed in the AGM HSCs (McKinney-Freeman 
et al., 2012); and FOS (Fig. 2 L), which was shown recently 
in cooperation with Gata2, Etv6, and Gfi1b to be sufficient 
to convert fibroblasts to endothelial cells capable of giving 
rise to hematopoietic cells (Pereira et al., 2013). Collectively, 
this bioinformatics screen suggests that the PKA–CREB 
and BMP pathways interact in the AGM, where emerging 
hematopoietic cells have endothelial characteristics (North 
et al., 2002).
BMP4 rescues AGM hematopoiesis  
from PKA–CREB inhibition
We investigated the interaction between the PKA–CREB 
and BMP pathways during AGM hematopoiesis, as predicted 
by bioinformatics, by examining the localization of the BMP 
ligand Bmp4 in the E11.5 AGM. Similar to the distribution of 
phospho-CREB (Fig. 1, C and D), Bmp4 was localized in cells 
lining the dorsal aorta and, more strongly, in the ventral than 
the dorsal mesenchyme, as previously reported (Fig. 3 A; Durand 
et al., 2007). In immediately adjacent sections, the tran-
scriptionally active BMP target protein complexes phospho-
Smad1/5 and Smad1/5/8 showed a similar distribution (Fig. 3, 
B and C). Upon closer examination of the ventral floor of the 
dorsal aorta, we observed cells with phospho-CREB in close 
proximity to Bmp4 (Fig. 3 D).
To directly modulate the PKA–CREB pathway within 
embryonic tissues, we dissected the AGM from E11.5 em-
bryos and isolated VE-cadherin+ cells (Fig. 3 E)—a fraction 
known to harbor HSCs (North et al., 2002)—and exposed 
these cells to chemical modulators or extracellular ligands. 
Using high-content immunofluorescence, we tracked the 
dynamics of pathway modulation by quantifying the nu-
clear localization of proteins at a single cell level using VE- 
cadherin+ cells isolated from differentiating mESCs. Exposure 
of these cells to KT5720, a potent inhibitor of PKA through 
competitive inhibition of ATP, reduced phospho-CREB in 
a dose-dependent fashion most strongly at 1 h after treatment 
(Fig. 3 F). Exposure to 5 µM of KT5720 significantly reduced 
CFU activity of VE-cadherin+ cells isolated from the E11.5 
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Figure 3. BMP4 rescues hematopoiesis from PKA–CREB inhibition. (A) Immunofluorescence section of the E11.5 AGM showing the co-localization 
of phospho-CREB and Bmp4. ao, dorsal aorta; nc, notochord; nt, neural tube. (B) Immunofluorescence of adjacent section to A showing the localization of 
phospho-Smad1/5/8. (C) Immunofluorescence of adjacent section to A showing the localization of phospho-Smad1/5. (D) Zoomed view of the ventral 
mesenchyme indicated by an arrow in A. (E) Experimental scheme for working with AGM-derived VE-cadherin+ cells. (F) Normalized high-content immuno-
fluorescence of the phospho-CREB dynamics upon KT5720 treatment over 8 h. n = 2. (G) CFU of sorted VE-cadherin+ cells from E11.5 per embryo equiva-
lent (e.e) treated with various compounds for 8 h. Representative multipotent CFUs at 12 d after plating shown on right. n = 3—5. (H) CFU assay of sorted 
VE-cadherin+ cells from E10.5 per e.e treated with various compounds for 8 h. n = 3. (I) CFU assay of sorted VE-cadherin cells from E10.5 per e.e treated 
with various compounds for 8 h. n = 3. (J) Example of peripheral blood analysis for donor chimerism for myeloid and lymphoid cell contribution using 
flow cytometry. (K) Donor chimerism levels at 12-wk after transplantation. 2.5 e.e. were used per recipient. Averages are shown in red. One-sided  
Wilcoxon rank-sum test was performed on log-transformed values. Bars: (A–C) 100 µm.
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Figure 4. Prohematopoietic effect of forskolin is dependent on BMP type I receptors. (A) Normalized high-content immunofluorescence of the  
phospho-CREB dynamics upon forskolin treatment over 8 h. n = 2. (B) Normalized high-content immunofluorescence of the phospho-Smad1/5/8 dynamics upon 
forskolin or BMP4 treatment over 8 h. n = 2. (C) CFU assay of sorted VE-cadherin+ cells per embryo equivalent (e.e) treated with various compounds for 8 h before 
assay. n = 3 – 9. (D) Representative multipotent CFUs from C at 12 d after plating. (E) CFU assay of sorted VE-cadherin+ cells from E10.5 per e.e treated with various 
640 Flow-induced PKA–CREB–BMP in AGM hematopoiesis | Kim et al.
of phenotypic HSCs, but rather a detectable change in 
HSC functionality.
Prohematopoietic effect of forskolin  
is dependent on BMP type I receptors
Because genomic CREB-binding sites overlap with SMAD1 
sites (Fig. 2, B and F), we explored whether forskolin 
activated SMAD1 target genes directly through CREB or 
whether the effect was dependent on the secretion of a 
BMP ligand. To test this, we used two different but specific 
BMP type I receptor ALK2/3/6 inhibitors LDN193189 
and dorsomorphin (Yu et al., 2008a,b). In agreement with 
previous studies on BMP signaling (Durand et al., 2007; 
Wilkinson et al., 2009), 10 µM dorsomorphin significantly 
reduced the hematopoietic CFUs compared with the con-
trol (Fig. 4 C). 4 µM LDN193189 showed a trend toward 
reduced hematopoietic activity but was not significant (Fig. 4 C; 
P = 0.11). When forskolin treatment was combined with 
LDN193189 or dorsomorphin, CFU activity was signifi-
cantly diminished as compared with the forskolin treat-
ment alone (Fig. 4 C). Additionally, CFU activity from the 
combination treatments was similar to inhibitor treatments 
alone. A similar result was obtained when we repeated the 
experiment with E10.5 AGM (Fig. 4 E). When we treated 
VE-cadherin cells, which includes CD41+/CD45+ hema-
topoietic cells, the treatment had no effect, confirming that 
the effect is specific to VE-cadherin+ cells (Fig. 4 F).To-
gether, these data suggest that the prohematopoietic effect 
of forskolin is dependent on BMP type I receptors.
To confirm this with in vivo transplantation experi-
ments, we sorted VE-cadherin+ cells from the E11.5 AGM and 
treated with forskolin, BMP4 ligand, or an inhibitor of the 
BMP type I receptor LDN193189. We then transplanted 
these treated cells into irradiated recipients and monitored 
donor chimerism. In agreement with the CFU data, forskolin 
and BMP4 showed a trend toward increased hematopoietic 
engraftment, and the combination treatment did not result 
in an additional increase in chimerism (Fig. 4 G). Multilineage 
engraftment upon secondary transplantation confirmed the 
long-term potential of these HSCs (Fig. 4 H). Moreover, he-
matopoietic engraftment was modestly decreased with the 
inhibition of BMP type I receptors (Fig. 4 G), confirming 
a ligand-dependent effect on engraftment. Curiously, some 
LDN193189-treated samples engrafted, suggesting that BMP 
signaling may be required for specification of HSCs but not 
thereafter (Fig. 4 G).
GEMM colonies (Fig. 4, C and D), whereas lineage-restricted 
colonies were less affected. We also observed a similar trend 
with BMP4 treatment, but the result was not significant 
(Fig. 4 C; P = 0.2). Both forskolin and BMP4 treatments have 
similar prohematopoietic effects on CFUs.
To assess whether PKA–CREB activation collaborates with 
pathways independent of BMP to promote hematopoiesis, 
we combined BMP4 and forskolin treatments. If forskolin 
activates hematopoietic pathways other than BMP, then the 
combination treatment should increase CFUs above that of 
forskolin treatment alone. However, 1 µM forskolin com-
bined with BMP4 did not result in additional enhancement 
(Fig. 4 C). The higher dose of forskolin combined with BMP4 
had an inhibitory effect on CFUs when compared with the 
control (Fig. 4 C), suggesting dose-sensitivity, possibly due to 
the role of BMP as a concentration-dependent morphogen.
Activation of adenylate cyclase can result in activation of 
Epac1/2 in addition to PKA (de Rooij et al., 1998) but 
Epac1 and Epac2 expression were absent in the AGM (un-
published data). Moreover, forskolin treatment did not re-
sult in activation of the Epac target pathway phospholipase 
C–epsilon (unpublished data), thus excluding its role in 
AGM hematopoiesis.
Because CREB activation drives antiapoptotic signals 
through induction of bcl-2 expression in B cells (Wilson et al., 
1996), we examined the effect of forskolin or BMP4 treat-
ment on the viability of AGM VE-cadherin+ cells. Cells ex-
posed to forskolin or BMP4 did not have significant changes 
in the percentage of apoptotic cells compared with the con-
trol, as assessed by Annexin V staining (unpublished data). 
Therefore, it is unlikely that the increase in hematopoiesis is 
caused by increased cell survival.
BMP4 treatment is known to expand the c-Kit low frac-
tion of AGM cells in culture (Marshall et al., 2007). If for-
skolin treatment induces the BMP pathway, then forskolin 
exposure should induce a similar surface phenotype as BMP4 
exposure. Accordingly, forskolin treatment resulted in a mod-
est trend toward an increase in c-Kit low fraction that is com-
parable to BMP4 treatment alone (unpublished data).
HSCs reside in the VE-cadherin+CD45+ fraction of the 
E11.5 AGM (North et al., 2002). We tested whether the for-
skolin or BMP4 treatment of AGM VE-cadherin+ cells in-
creases the absolute number of VE-cadherin+CD45+ cells. 
However, we did not observe any significant increase in these 
cells with forskolin treatment (unpublished data). This sug-
gests that there is not an appreciable change in the number 
compounds for 8 h. n = 3. (F) CFU assay of sorted VE-cadherin cells from E10.5 per e.e treated with various compounds for 8 h. n = 3. (G) Donor chimerism levels 
at 12 wk after transplantation. Averages are shown in red. One-sided Wilcoxon rank-sum test was performed on log-transformed values. (H) Donor chimerism 
levels at 12–16 wk after secondary transplantation from top 4 engrafted recipients from Figs. 3 I and 4 E. Averages are shown in red. (I) Violin plots showing the 
quantification of BMP4 via immunofluorescence upon forskolin or H89 treatment in VE-cadherin+ cells isolated from the E11.5 AGM. Significance was assessed 
using the two-sided Wilcoxon-rank sum test. (J) Violin plots showing the quantification of phospho-Smad1/5/8 via immunofluorescence upon forskolin or H89 
treatment of VE-cadherin+ cells isolated from the E11.5 AGM. Significance was assessed via the two-sided Wilcoxon-rank sum test. (K) Immunofluorescence for 
Bmp4 and phospho-Smad1/5/8 in VE-cadherin+ cells isolated from the E11.5 AGM and treated with forskolin or H89. Red arrowhead, phospho-Smad1/5/8 near a 
Bmp4 secreting cell. White arrowhead, Phospho-Smad1/5/8 in the same cell secreting Bmp4. Bars, 50 µm.
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VE-cadherin+ cells near cells secreting the Bmp4 ligand and 
phospho-Smad1/5/8 in Bmp4-secreting cells, indicative of 
both autocrine and paracrine signaling (Fig. 4 K).
Global transcriptome shift demonstrating  
BMP pathway activation
To confirm the BMP pathway activation via microarray analy-
sis, we evaluated gene expression changes in forskolin or 
BMP4-treated VE-cadherin+ cells from the AGM. First we 
investigated whether forskolin-treated cells up-regulated BMP 
ligands. Indeed, forskolin modestly up-regulated Bmp2/4, 
which are both ligands of the BMP type I receptors (Fig. 5 A). 
The expression of the BMP type I receptors Bmpr1a or Bmpr1b 
were not altered when compared with the control consistent 
Although the hematopoietic effect of forskolin was de-
pendent on the BMP type I receptors, the source of BMP li-
gands was unknown because serum-free media was used to 
culture VE-cadherin+ cells. We hypothesized that sorted VE-
cadherin+ cells are able to release Bmp ligands and signal to 
other VE-cadherin+ cells via paracrine or autocrine signaling. 
To confirm this, we sorted VE-cadherin+ cells from the AGM 
and quantified Bmp4 ligand release via high-content immuno-
fluorescence after PKA–CREB activation with forskolin. 
Bmp4 secretion per cell was significantly increased with for-
skolin treatment (Fig. 4 I). Conversely, inhibition of PKA–CREB 
signaling via the H89 compound decreased Bmp4 secre-
tion (Fig. 4 I), as well as the BMP target phospho-Smad1/5/8 
(Fig. 4 J). We found instances of phospho-Smad1/5/8 in 
Figure 5. Transcriptome analysis reveals evidence of PKA–CREB–BMP signaling in VE-cadherin+ cells. (A) Up-regulation of BMP ligands and 
target genes upon forskolin treatment. n = 2. (B) Violin plot of BMP4-responsive target genes that are detectable via presence/absence calls upon for-
skolin treatment. Statistical significance via the two-sided Wilcoxon-rank test. n = 2. (C) Transcription factors significantly up-regulated by each treat-
ment (F, forskolin; B, BMP4). Numbers indicate significantly up-regulated genes. n = 2. (D) Quantitative RT-PCR on selected BMP target genes Id1-3 and 
Gata2 upon forskolin treatment. n = 4. (E) Selected CREB and BMP target genes analyzed in the nonhemogenic endothelium, hemogenic endothelium, 
and hematopoietic progenitors (GSE52075; Swiers et al., 2013). n = 3. (F) Violin plot of BMP4 target genes similar to B) in the nonhemogenic endothe-
lium, hemogenic endothelium and hematopoietic progenitors (GSE52075; Swiers et al., 2013). Statistical significance via the two-sided Wilcoxon-rank 
test. n = 3.
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E9.5 murine embryos lacking a heartbeat and intravascular 
flow due to a homozygous mutation in the Na+/Ca2+ ex-
changer Ncx1 (Koushik et al., 2001). These mice are shown 
to have shear-stress dependent hematopoietic defects at E9.5 
in the PSp (Lux et al., 2008; Adamo et al., 2009), which later 
matures into the AGM.
The embryonic lethality of these mice at E9–10 precludes 
further analysis of definitive hematopoiesis via transplanta-
tion (Medvinsky and Dzierzak, 1996; Koushik et al., 2001). 
Despite this limitation, we examined histological sections of 
Ncx1-null embryos to explore the relationship between intra-
vascular flow and the PKA–CREB–BMP signaling axis. In 
the E9.5 wild type littermates, the two dorsal aortae have 
fused to a single dorsal aorta, in agreement with previous 
studies (Fig. 6, A–E; Nagase et al., 2006). Phospho-CREB was 
present in the mesenchyme surrounding the dorsal aorta, the 
cells lining the dorsal aorta and the neural tube (Fig. 6 B). In 
agreement with the E11.5 distribution of phospho-CREB 
and Bmp4 (Fig. 3 A), phospho-CREB and Bmp4 in the E9.5 
embryos were also present at higher levels in the ventral mes-
enchyme surrounding the dorsal aorta (Fig. 6, B and C). In the 
E9.5 Ncx1-null embryos, we observed a delay in the fusion 
of the dorsal aortae that occurs between E8–9.5 (Fig. 6, F–J), 
which is consistent with the growth retardation phenotype 
previously documented (Koushik et al., 2001). Consistent 
with the PKA–CREB–BMP axis as a blood flow-responsive 
pathway, we observed a decrease in phospho-CREB in the 
mesenchyme surrounding the two dorsal aortae and a stron-
ger decrease in phospho-CREB in the cells lining the dorsal 
aorta when compared with the neural tube (Fig. 6 G). Bmp4 
was similarly decreased but not absent when compared with 
the control (Fig. 6, H and I). Quantification of phospho-CREB+ 
cells in multiple sections revealed significant decrease with 
Ncx1 KO embryos (Fig. 6 K). Similar result was obtained with 
phospho-Smad1/5/8, a BMP target protein (Fig. 6 L).
To determine whether exogenous shear stress can in-
crease PKA–CREB–BMP signaling in the AGM, we sorted 
VE-cadherin+ cells from the AGM and subjected them to 6 h 
of shear stress. Shear stress increased phospho-CREB levels, 
and this effect was mitigated by 2 µM of H89, a PKA inhibi-
tor (Fig. 6 M). Furthermore, Bmp4 was detected upon appli-
cation of shear stress but also decreased with H89 treatment 
(Fig. 6 M). BMP4 transcript is found in endothelial cells ex-
posed to shear stress, especially oscillatory shear stress (Fig. 6 N; 
Ni et al., 2011). This may be similar to the retrograde flow 
experienced before formation of cardiac outflow tract cush-
ions and valves at E11.5 and E13.5, respectively ( Ji et al., 
2003; Vermot et al., 2009).
Finally, we examined whether PKA–CREB–BMP signal-
ing axis can restore the hematopoietic activity in the absence 
of shear stress. AGM explants from E9.5 Ncx1 KO embryos 
have reduced hematopoietic progenitor activity in the PSp 
due to the lack of blood flow (Adamo et al., 2009). When 
AGM explants from E9.5 Ncx1 KO embryos were exposed to 
exogenous BMP4 or forskolin (1 µM) for 24 h, CFU activity 
was increased, suggesting a partial rescue via modulation of 
with a ligand-dependent effect (Fig. 5 A). Forskolin treatment 
also up-regulated genes co-bound by CREB and SMAD1 
(Fig. 2, G–L) but the effect was less prominent than BMP4 
treatment alone (Fig. 5 A).
Because the effect of forskolin on selected BMP targets 
was weaker than BMP4, we assessed whether we could detect 
a global up-regulation in BMP target genes in the forskolin-
treated cells. BMP4 treatment significantly up-regulated 147 
genes (p-value cut-off, 0.01). Forskolin-treated cells also had 
a significant global up-regulation in these BMP target genes 
that are present (Fig. 5 B; P = 0.02), thus confirming that 
PKA–CREB activation results in global BMP target gene 
up-regulation.
Given the up-regulation of the BMP target genes, we ex-
pected an overlap in the hematopoietic transcription factors 
significantly up-regulated by forskolin or BMP4 treatment. 
Surprisingly, there was no overlap of up-regulated transcrip-
tion factors (Fig. 5 C). We hypothesized that this was due to 
the short duration of treatment that resulted in up-regulation 
of genes below the significance threshold. To test this further, 
we examined the genes up-regulated by the combination 
treatment of forskolin and BMP4 and found a stronger activa-
tion of factors important for AGM HSC formation, such as 
Gata2 (Creyghton et al., 2010) and Gata3 (Fitch et al., 2012), 
as well as factors important for adult HSC maintenance such as 
Pbx1 (Ficara et al., 2008) compared with either treatment 
alone (Fig. 5 C).
Finally, we confirmed the up-regulation of several BMP 
target genes (Id1, Id3, and Gata2) upon forskolin treatment by 
quantitative RT-PCR (Fig. 5 D). Together, these data suggest 
that forskolin and BMP4 up-regulate common BMP targets, 
including those with known roles in hematopoiesis.
CREB–BMP in the hemogenic endothelium
To confirm the activity of CREB–BMP signaling in the 
hemogenic endothelium, we analyzed published microarray 
data on the hemogenic endothelium characterized using the 
Runx1+23 enhancer-GFP transgenic mice (Swiers et al., 2013). 
At the onset of circulation, both the hemogenic endothe-
lium and nonhemogenic endothelium up-regulated selected 
CREB–BMP targets, whereas hematopoietic progenitors did 
not (Fig. 5 E). Global BMP target up-regulation was signifi-
cantly increased only in the hemogenic endothelium as com-
pared with the hematopoietic progenitors but not in the 
nonhemogenic endothelium (Fig. 5 F). Together with the 
immunostaining and CFU data (Figs. 1 D, 3 I, and 4 F), this 
suggests that hemogenic endothelial cells respond to CREB–
BMP signaling but hematopoietic progenitors do not.
Shear stress dependence of the CREB–BMP signaling axis
We hypothesized that the PKA–CREB–BMP signaling axis 
is a blood-flow dependent pathway because phospho-CREB 
in VE-cadherin+ cells increased with shear stress in vitro (Fig. 1 F) 
and because the localization of the factors involved in this 
signaling axis were expressed close to or within the cells lin-
ing the dorsal aorta (Fig. 3 A). To confirm this, we examined 
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Figure 6. Shear stress–dependent regulation of 
CREB–BMP axis. (A–E) Frozen sections of the E9.5 
wild-type PSp stained with phospho-CREB and Bmp4. 
(D–E) Merged image of A–C. (E) Magnified view of the 
boxed area in D. ao, dorsal aorta/e; nt, neural tube; vm, 
ventral mesenchyme. Bars, 100 µm. White outline  
contains cells facing the lumen of the dorsal aorta.  
(F–J) Frozen sections of the E9.5 Ncx1-null PSp with two 
dorsal aortae stained with phospho-CREB, Bmp4.  
(I–J) Merged image of F–H. (J) Magnified view of the boxed 
area in I. White outline contains cells facing the lumen  
of the dorsal aorta. (K) Quantification of phospho-CREB 
excluding cells in the neural tube in WT and Ncx1 KO 
embryos. Quantification based on three independent 
embryos. (L) Quantification of phospho-Smad1/5/8 ex-
cluding cells in the neural tube in WT and Ncx1 KO em-
bryos. Quantification based on three independent 
embryos. (M) Immunoblot showing the effect of shear 
stress and/or PKA inhibitor H89 on phospho-CREB, 
Bmp4, on VE-cadherin+ cells sorted from the AGM.  
(N) Differential effect of laminar shear stress (LS) and 
oscillatory shear stress (OS) on the expression of BMP4 
in endothelial cells (GSE20739; Ni et al., 2011). n = 3.  
(O) Rescue of defective hematopoiesis in E9.5 Ncx1 PSp 
with forskolin or BMP4 treatment. n = 4.
the PKA–CREB–BMP signaling axis (Fig. 6 O). Collec-
tively, our data suggests that the PKA–CREB–BMP axis is a 
blood flow–dependent signaling axis responsible for hemato-
poietic development.
DISCUSSION
In this study, we have shown that the PKA–CREB pathway 
is a novel shear-responsive pathway that acts via BMP to 
promote AGM hematopoiesis. Chemical modulation of the 
PKA–CREB–BMP signaling axis implicates PKA–CREB 
signaling as necessary for AGM hematopoiesis, and demon-
strates dependence on BMP type I receptors. Surprisingly, 
VE-cadherin+ cells secrete BMP ligands in response to the 
activation of PKA–CREB, thus promoting hematopoietic 
development in neighboring VE-cadherin+ cells in an autocrine-
paracrine manner. At the genomic level, the BMP target SMAD1 
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Bmp4 is a ventral signal arising from the mesenchyme that 
promotes hematopoietic development. Zebrafish data largely 
fine-tunes this theory by suggesting that the BMP ligands 
from the ventral mesenchyme and the pronephros region po-
larize the dorsal aorta opposed with Hedgehog ligands from 
the notochord (Wilkinson et al., 2009). In our study, BMP 
ligands are also found ventrally, but we propose a new source 
of BMP ligands in the AGM that has been previously under-
appreciated. We suggest that BMP ligands are generated 
autonomously within VE-cadherin+ cells upon PKA–CREB 
stimulation via shear stress (Figs. 4 I and 5 A). Combined with 
other signals from the mesenchyme, BMP ligands activate 
a hematopoietic transcriptional program in neighboring VE-
cadherin+ cells that have been exposed to shear stress, thus 
promoting HSC emergence. Emerging hemogenic endothe-
lial cells have the signature of global BMP target gene up-
regulation. Evidence suggests that CREB can directly bind to 
the promoter of genes encoding BMP ligands in other cell 
types (Zhang et al., 2011). However, the question of direct 
binding of CREB to this promoter remains to be answered in 
the rare AGM cells that give rise to HSCs. Although we did 
not deplete the rare CD41 or CD45 positive hematopoietic 
fractions, the observed hematopoietic output after 8 h expo-
sure to chemicals and ligands is suggestive of cell fate transi-
tions rather than hematopoietic cell division. To confirm 
this, we calculated the mean doubling time of AGM hemato-
poietic cells using published data (Taoudi et al., 2008). Be-
cause E11.5 AGM-derived cells undergo expansion from 
3,640–32,130 cells in a 96-h period, we estimated that the 
doubling time is 30 h, which is much greater than our ex-
posure time in distinct cell types.
The ligand and mechanosensors responsible for the acti-
vation of PKA is still in question. Many different signaling 
modules can activate PKA, including prostaglandins (e.g., 
PGE2) through the prostanoid receptor (Goessling et al., 
2009); inflammatory cytokines through interferon signaling 
(Liu et al., 2004), calcium flux, purinergic ( Jing et al.; accom-
panying paper); and -adrenergic signaling. Because of recent 
evidence suggesting that PGE2 is synthesized in response to 
shear stress (Cherian et al., 2003; Ogawa et al., 2014), and the 
proposed role of PGE2 in embryonic hematopoiesis (Goessling 
et al., 2009), PGE2 is a candidate upstream of PKA for the ex-
ploration of shear stress–mediated signaling (Diaz et al.; ac-
companying paper). Indeed, PGE2 can up-regulate BMP4 in 
human CD34+ cord blood cells (Goessling et al., 2011). How-
ever, as many of these pathways can activate PKA, further 
studies will be required to dissect the relative contributions of 
individual pathways that signal through PKA–CREB.
Biomechanical forces likely have a multifactorial effect 
on emerging HSC precursors that cannot be replicated by the 
modulation of a single signaling pathway. Although the PKA–
CREB–BMP signaling axis is necessary for HSC emergence, 
the modest and incomplete rescue of Ncx1 KO embryos upon 
exogenous administration of BMP ligands or PKA agonists 
suggest that other pathways, such as Wnt or Notch pathways, 
are also at play.
and CREB co-regulate several factors involved in hemato-
poietic induction, such as Gata2. In Ncx1-null embryos lack-
ing intravascular flow, the PKA–CREB–BMP signaling axis is 
blunted. Our data establish a mechanism by which mechani-
cal forces are translated into molecular signals for governing 
HSC emergence.
The relationship between biomechanical forces and he-
matopoietic development has only recently begun to be elu-
cidated (Adamo et al., 2009; North et al., 2009; Wang et al., 
2011). The striking correlation between the onset of a heart-
beat at E8.5 in the mouse, and the emergence of HSCs with 
the ability to engraft various types of recipients—such as neo-
natal recipients at E9 (Yoder et al., 1997; Arora et al., 2014), 
and adult recipients at E10–11 (Medvinsky and Dzierzak, 
1996; North et al., 2002)—suggests that biomechanical forces 
and hematopoietic development are intricately linked. Past 
studies have focused on the nitric oxide pathway as an impor-
tant mediator of shear stress (Adamo et al., 2009; North et al., 
2009; Wang et al., 2011). Blastula transplantation experi-
ments in zebrafish have demonstrated a cell autonomous re-
quirement for nitric oxide signaling during hematopoietic 
development (North et al., 2009), but further work is re-
quired to decipher whether nitric oxide has a direct inductive 
effect on hematopoietic precursors or whether this is a sec-
ondary effect caused by vasodilation. Shear-dependent pro-
grams in zebrafish and mouse may also differ because blood 
flow is not required for the initiation of runx1+ definitive he-
matopoiesis in zebrafish (Wang et al., 2011), but is required 
for hematopoietic colony formation from the E9 mouse PSp, 
an early precursor to the AGM (Adamo et al., 2009). Here, 
we show that the PKA–CREB–BMP signaling axis is a novel 
shear-dependent pathway that has a direct inductive effect 
on VE-cadherin+ precursors. This induction of a hematopoi-
etic program in VE-cadherin+ cells involves a phenomenon 
called the endothelial-to-hematopoietic transition because our 
effects are specific to the VE-cadherin+ but not the VE- 
cadherin fraction, which contain mature hematopoietic cells. 
Indeed, most of the emerging hemogenic endothelial cells as 
defined by Sca1-GFP are also phospho-CREB+. Interest-
ingly, activation of PKA results in up-regulation of Foxc2, 
which has been recently identified to play a role in the hemo-
genic endothelium (Jang et al., 2015). The endothelial-to-
hematopoietic transition has garnered recent interest because 
lineage tracing and live-imaging studies have shown that HSCs 
emerge from the VE-cadherin+ vascular endothelium in the 
AGM (Chen et al., 2009; Bertrand et al., 2010; Boisset et al., 
2010). Efforts to understand this phenomenon in humans 
have culminated in various protocols for ESC differentiation 
(Kennedy et al., 2012).
Numerous studies on BMP signaling and AGM hemato-
poietic development have hinted at its role in the endothelial-
to-hematopoietic transition. Bmp4 was originally identified 
in the murine stromal lines derived from the urogenital ridges 
of the AGM and have been found to increase the in vivo re-
populating ability of AGM HSCs when co-cultured with 
stromal lines for 3 d (Durand et al., 2007). In their model, 
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cells via tail vein injection, along with 2 × 104 bone marrow or 2 × 105 
splenic helper cells per experiment group from B6.SJL-Ptprca mice unless 
indicated otherwise. For secondary transplantations, CD45.2+ cells were iso-
lated from recipient bone marrow and 3 × 105 cells were transplanted per 
recipient with 2 × 105 splenic helper cells. Peripheral blood was collected 
retroorbitally at the indicated time point after transplantation. Red blood cells 
were removed with 1% dextran sulfate/0.5% EDTA/PBS (wt/vol) and 
treated with RBC lysis buffer (Sigma-Aldrich). Leukocytes were then stained 
in 2% serum/PBS (vol/vol) for CD45.1-FITC (A20; BD), CD45.2-PE-Cy7 
(104; BioLegend), Mac1-Alexa Fluor 700 (M1/70; BioLegend), Gr1-PE 
(A20; BD), CD19-APC-Cy7 (6D5; BioLegend), CD3-APC (145-2C11; 
eBioscience), Ter119-PE-Cy5 (TER-119; eBioscience), B220-Pacific Blue 
(RA3-6B2; BD), and propidium iodide (PI). Engraftment was determined 
to be a percentage of PI and Ter119-negative CD45.2 cells within the 
CD45-positive population.
Western blotting. Cells were lysed in RIPA buffer with protease and 
phosphatase inhibitors (Thermo Fisher Scientific). Proteins were separated 
via polyacrylamide gel and transferred to an activated PVDF Membrane. 
Membrane was blocked for 1 h using 5% milk or 5% BSA in PBST or Odys-
sey Blocking Buffer (LI-COR) and probed with primary antibodies over-
night at 4°C. After washing with PBST, HRP-conjugated secondary antibodies 
were used for 1 h at room temperature (GE Healthcare). Protein level was 
detected using SuperSignal West Pico and Femto Luminol reagents (Thermo 
Fisher Scientific). The following antibodies were used: phospho-CREB 
(Cell Signaling Technology), CREB (Cell Signaling Technology), phospho-
S675--catenin (Cell Signaling Technology), active -catenin (Cell Signaling 
Technology), -catenin (BD), Bmp4 (Millipore).
High-content immunofluorescence microscopy. Cells were cultured 
in 96-well optical-bottom plates (Corning). Cells were fixed with 2% para-
formaldehyde for 15 min and permeabilized with methanol at 20°C for 
10 min. Cells were blocked with Odyssey Blocking Buffer (LI-COR) for 
1 h at room temperature. Cells were stained in this blocking buffer. Primary 
antibody was incubated overnight and secondary antibody was incubated at 
room temperature for 1 h. Cells were imaged with ImageXpress Micro. 
Nine image fields were collected for each well and processed with an image 
segmentation routine derived from CellProfiler (Carpenter et al., 2006), 
with Otsu global thresholding for nuclear identification. Single-cell fluor-
escence intensity was calculated as mean fluorescence intensity per nucleus 
or per cell.
Histological analysis. For paraffin sections, E10.5 or E11.5 mouse em-
bryos were fixed in 4% paraformaldehyde on ice for 1 h before embedding 
in paraffin and sectioning. Paraffin-embedded sections were dewaxed with 
xylene and rehydrated with decreasing percentages of ethanol. Antigen re-
trieval was performed using 10 mM sodium citrate buffer, pH 6.0, using a 
pressure cooker at 95°C for 30 min.
For frozen sections, E9.5 mouse embryos were fixed in 4% paraformal-
dehyde on ice for 2–3 h, followed by equilibration in 30% sucrose in PBS 
solution overnight. The tissues were placed in 1:1 30% sucrose/OCT (Tissue-
Tek; Electron Microscopy Sciences) solution for 1 h, 100% OCT for 1 h, 
and then embedded in 100% OCT compound. The blocks were immedi-
ately frozen on dry ice with isopropanol and stored at 80°C. The sections 
were cut at 20 µm with a Leica CM3050 S cryostat.
Cells were permeabilized with Triton X-100 (0.01%) and blocked for 
1 h with 10 mM glycine in host serum corresponding to the secondary anti-
body before staining. Immunostaining was performed with the following 
primary antibodies overnight: phospho-CREB (Cell Signaling Technology), 
CREB (Cell Signaling Technology), Bmp4 (Millipore), phospho-Smad1/5 
(Cell Signaling Technology), phospho-Smad1/5/8 (Cell Signaling Technol-
ogy), and GFP (Abcam). For secondary antibody staining, Alexa Fluor 488–, 
Alexa Fluor 568–, or Alex Fluor 647–conjugated goat anti–rabbit or goat anti–
mouse secondary antibodies were used. DAPI-stained cells were mounted 
with VECTASHIELD mounting medium (Vector Labs). All images were 
This current study shows using sorted VE-cadherin+ cells 
from the mouse AGM as well as Ncx1-null embryos that the 
PKA–CREB–BMP signaling axis is a blood flow–dependent 
pathway that has hematopoietic inductive effects on VE- 
cadherin+ cells. Further studies will help explain the con-
centration-dependent effects of the PKA–CREB and BMP 
pathways and address why only rare cells are endowed with 
the required gene expression programs to become HSCs. Study 
of the signaling pathways linking biomechanical stimuli to 
intracellular events will help elucidate the pathways required 
to promote HSC formation from ESCs for cellular therapy.
MATERIALS AND METHODS
Cell culture and differentiation. mESCs were cultured on irradiated 
CF1s with leukemia inhibitory factor (LIF), as previously described (Kim 
et al., 2013). Embryoid body differentiation was performed as previously de-
scribed (Kim et al., 2013). In brief, mESCs were aggregated via hanging 
drop method, and then collected on day 2–2.25, and then collected on day 
6 of differentiation and dissociated using DNase I, Collagenase IV, and Hy-
aluronidase for further analysis. For shear stress applications, oscillatory shear 
stress of 10 dynes/cm2—corresponding to an order of magnitude of previ-
ous calculations (Adamo et al., 2009)—was applied to a 10-cm tissue culture 
dish via 150 rpm of orbital shaking. Maximum shear stress (max) was ap-
proximated via max = a((2f)3)1/2, where a is the orbital radius,  is the 
fluid density,  is the fluid viscosity, and f is the frequency of orbit (Ley et al., 
1989). Variations in shear stress were decreased via peripheral cell attachment 
(dela Paz et al., 2012).
Mouse embryo culture. All animal procedures were conducted according 
to animal care guidelines approved by the Institutional Animal Care and 
Use Committee at Boston Children’s Hospital. E9.5, E10.5, or 11.5 staged 
mouse embryos were obtained using timed pregnancies of C57BL/6 females 
unless specified. The AGM region was isolated under a dissecting micro-
scope and dissociated to single cells using DNase I, Collagenase IV, and Hy-
aluronidase for 20 min. The cells were then passed through a 40-µm filter 
and washed with IMDM. Cells were first stained with 1:10 dilution of VE-
cadherin (11D4.1), then labeled with anti–rat IgG2a-PE (RG7/1.30) for sort-
ing on FACSAria or anti-PE/anti–rat MicroBeads (Miltenyi Biotec) for 
magnetic sorting. For magnetic sorting, each staining step was performed for 
15 min in 2% BSA/IMDM (vol/vol) at 4°C. All antibodies were obtained 
from BD unless indicated otherwise. Cells obtained via sorting were cultured in 
serum-free media containing 2% BSA/IMDM (vol/vol) supplemented with 
insulin-transferrin-selenium (ITS-G; Life Technologies), 25 µg/ml ascorbic 
acid, 450 µM monothioglycerol, 2 mM penicillin/streptomycin/glutamate, 
and 20 ng/ml VEGF (R&D Systems), 50 ng/ml IL3 (R&D Systems), 
50 ng/ml IL-6 (R&D Systems), 50 ng/ml SCF (R&D Systems), 50 ng/ml 
FLT3L (R& D Systems), 50 ng/ml TPO (R&D Systems), and 50 ng/ml 
IL6R (SBH Sciences). The sorted cells were reaggregated in the presence of 
chemicals or ligands for 8 h in a 96-well V-bottom plate. The cells were then 
dissociated with enzyme-free dissociation buffer and washed with IMDM 
before further analysis.
CFU assays. Cells were plated into 1.5–2 ml of methylcellulose media con-
taining interleukin-3 (IL-3), IL-6, erythropoietin (Epo), and SCF (M3434; 
StemCell Technologies) as described (Kim et al., 2013). CFUs (definitive 
erythroid [Ery], myeloid [M], granulocyte-macrophage [GM], granulocyte-
erythrocyte-monocyte-megakaryocyte multilineage [GEMM]) were scored 
based on morphology 10 d after plating.
Transplantation and peripheral blood analysis. B6.SJL-Ptprca mice 
were used at 6–10 wk of age. Mice were irradiated with a split dose of 9GY 
before transplantation. Each recipient received 1 embryo equivalent of sorted 
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standard error. Statistical significance is indicated by *, P = 0.05; **, P = 
0.01; ***, P = 0.001.
Online supplemental material. Table S1, available as an Excel file, shows 
SRA reference IDs for ChIP-sequencing. Table S2, available as an Excel file, 
shows a list of primers used in this study. Table S3, available as an Excel 
file, shows microarray gene expression data. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20141514/DC1.
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